Cure My Disease

Don't miss your cure!

 Log in / Sign up

New mapping tech aims to improve heart ablation for AFib patients

NCT ID NCT06808217

Ongoing Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 29, 2026 · Updated 3 times

Summary

This registry tracks 550 people with atrial fibrillation who are treated with the FARAPULSE pulsed field ablation system, using a special catheter and mapping technology. The goal is to see how safe and effective the procedure is in real-world settings over one year. Researchers will look at complications and how well the treatment controls the heart rhythm.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
FARAPULSE Pulsed Field Ablation System (device)
What this could lead to
If successful, this could confirm that using the FARAPULSE system with advanced mapping improves safety and success rates for treating atrial fibrillation.
What could go wrong
This is an observational registry, not a randomized trial, so results may not prove cause and effect. Risks include procedure-related complications like bleeding or heart rhythm issues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION FARAPULSE PULSED-FIELD ABLATION

Contacts and locations

Locations

  • Allgemeines Krankenhaus AKH

    Vienna, Austria

  • Asklepios Klinik Saint Georg

    Hamburg, Germany

  • CHRU de Clermont-Ferrand

    Clermont-Ferrand, France

  • CHU Grenoble

    Grenoble, France

  • CHU de Saint-Etienne

    Saint-Priest-en-Jarez, France

  • Cardiocentro Ticino

    Lugano, Switzerland

  • Centre Cardiologique du Nord

    Saint-Denis, France

  • Centre Hospitalier Princesse Grace

    Monaco, Monaco

  • Clinica Montevergine

    Mercogliano, Italy

  • Clinique Pasteur

    Toulouse, France

  • Eramus MC- University Medical Center

    Rotterdam, Netherlands

  • Henry Dunant Hospital Center

    Athens, Greece

  • Hospital Clinico San Carlos

    Madrid, Spain

  • Hospital Europeen Georges-Pompidou (HEGP)

    Paris, France

  • Hospital de Basurto

    Bilbao, Spain

  • Hospital de la Pitie-Salpetriere

    Paris, France

  • Ippokrateio General Hospital

    Thessaloniki, Greece

  • Isala Klinieken

    Zwolle, Netherlands

  • MVZ CCB Frankfurt und Main-Taunus GbR

    Frankfurt, Germany

  • Mater Private Hospital

    Dublin, Ireland

  • University Hospital Zurich

    Zurich, Switzerland

  • Vivantes Klinikum Am Urban

    Berlin, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.